Shanghai Haoyuan Chemexpress Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Haoyuan Chemexpress has a total shareholder equity of CN¥2.7B and total debt of CN¥988.0M, which brings its debt-to-equity ratio to 36.3%. Its total assets and total liabilities are CN¥4.7B and CN¥2.0B respectively. Shanghai Haoyuan Chemexpress's EBIT is CN¥188.0M making its interest coverage ratio 5.4. It has cash and short-term investments of CN¥497.4M.
Key information
36.3%
Debt to equity ratio
CN¥988.05m
Debt
| Interest coverage ratio | 5.4x |
| Cash | CN¥497.45m |
| Equity | CN¥2.72b |
| Total liabilities | CN¥1.96b |
| Total assets | CN¥4.68b |
Recent financial health updates
Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?
Oct 16
Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet
Jun 13Recent updates
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Shares Climb 36% But Its Business Is Yet to Catch Up
Nov 06Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?
Oct 16Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 25% Jump Shows Its Popularity With Investors
Sep 19Investors Appear Satisfied With Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Prospects
Jul 13Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet
Jun 13Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders
May 06After Leaping 27% Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) Shares Are Not Flying Under The Radar
Mar 20Financial Position Analysis
Short Term Liabilities: 688131's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 688131's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥751.8M).
Debt to Equity History and Analysis
Debt Level: 688131's net debt to equity ratio (18%) is considered satisfactory.
Reducing Debt: 688131's debt to equity ratio has increased from 8% to 36.3% over the past 5 years.
Debt Coverage: 688131's debt is well covered by operating cash flow (29.3%).
Interest Coverage: 688131's interest payments on its debt are well covered by EBIT (5.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Haoyuan Chemexpress Co., Ltd. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Citic Securities Co., Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |
| Mingrui Wang | Everbright Securities Co. Ltd. |